Today: 20 June 2026
Browse Category

NASDAQ:MESO 3 October 2025 - 12 January 2026

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast shares closed at $17.02 on Oct. 2, up 4.6% after the FDA-approved Ryoncil won permanent CMS reimbursement via a new J-code. The company confirmed its cell therapies are made from U.S. donors and not subject to tariffs. Wall Street consensus is “Buy” with a $24 average price target. Hedge funds have increased stakes, but overall institutional ownership remains low.
3 October 2025
··

Stock Market Today

  • Americans' 401(k) Balances Reach Record Highs in 2023, Vanguard Report Shows
    June 20, 2026, 11:12 AM EDT. Americans' 401(k) retirement savings hit record levels in 2023, according to Vanguard's annual "How America Saves" report. The data reflects broad gains across workplace retirement accounts, driven by steady contributions and market growth. Vanguard, a global investment management company, noted improved balances benefiting many savers nationwide. The report offers benchmarks for individuals to compare their account performance against national trends. Analysts attribute the rise to a combination of favorable market conditions and increased participation in retirement plans. The findings underscore ongoing positive momentum in Americans' preparation for retirement amid economic uncertainties.

Latest articles

PayPal edges higher as questions linger over turnaround

PayPal edges higher as questions linger over turnaround

20 June 2026
PayPal shares ended a holiday-shortened week up 2.4% at $42.51 as investors weighed cost cuts, Venmo’s 14% payment volume growth, and a pause in new PayPal Ventures investments against continued weak branded checkout growth and management’s warning of more pressure in Q2.
Insurers scramble to address AI health fraud while liability cover falls short

Insurers scramble to address AI health fraud while liability cover falls short

20 June 2026
AI-powered healthcare fraud is surging as insurers face thousands of bot calls and fake medical records, raising claims screening costs and exposing gaps in policy coverage, with Gallagher warning “silent AI” risks could drive higher claim frequency and severity, while only half of AI-related losses are fully insured.
Go toTop